drugset / Trial / NCT00380939

This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.

NCT00380939

Phase 4 Completed 600 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to assess the effects on coronary artery plaque using aggressive lipid-lowering therapy versus moderate lipid-lowering therapy. A substudy will examine the effect of these treatments on brachial artery vasoactivity.

Timeline

Start
1999-04
Primary completion
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Pravastatin Small molecule